Pathological	O
animal	O
models	O
in	O
the	O
experimental	O
evaluation	O
of	O
tumour	B-Tissue
microvasculature	I-Tissue
with	O
magnetic	O
resonance	O
imaging	O
.	O

PURPOSE	O
:	O
The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
applications	O
of	O
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
)	O
,	O
and	O
in	O
particular	O
,	O
dynamic	O
contrast	O
-	O
enhanced	O
MRI	O
(	O
DCE	O
-	O
MRI	O
)	O
,	O
in	O
the	O
assessment	O
of	O
tumour	B-Tissue
microvasculature	I-Tissue
by	O
means	O
of	O
animal	O
tumour	B-Cancer
models	O
evaluated	O
before	O
and	O
after	O
antiangiogenic	O
treatment	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
Forty	O
-	O
two	O
MRI	O
exams	O
were	O
performed	O
with	O
intravascular	B-Immaterial_anatomical_entity
contrast	O
media	O
in	O
21	O
rats	O
:	O
tumours	B-Cancer
were	O
induced	O
by	O
subcutaneous	B-Immaterial_anatomical_entity
injection	O
of	O
colon	B-Cell
carcinoma	I-Cell
cells	I-Cell
in	O
7	O
rats	O
and	O
mammary	B-Cell
adenocarcinoma	I-Cell
cells	I-Cell
in	O
14	O
rats	O
.	O

Perfusion	O
and	O
permeability	O
parameters	O
of	O
the	O
implanted	O
tumours	B-Cancer
were	O
evaluated	O
by	O
using	O
two	O
contrast	O
media	O
(	O
B22956	O
/	O
1	O
and	O
Gd	O
-	O
DTPA37	O
-	O
albumin	O
)	O
to	O
establish	O
response	O
to	O
treatment	O
with	O
two	O
different	O
antiangiogenic	O
drugs	O
(	O
tamoxifen	O
and	O
SU6668	O
)	O
.	O

These	O
parameters	O
were	O
correlated	O
with	O
histology	O
to	O
obtain	O
a	O
radiological	O
-	O
histological	O
map	O
of	O
tumour	B-Tissue
microvasculature	I-Tissue
.	O

RESULTS	O
:	O
DCE	O
-	O
MRI	O
revealed	O
greater	O
enhancement	O
in	O
the	O
peripheral	B-Organism_subdivision
area	I-Organism_subdivision
than	O
in	O
the	O
central	B-Organism_subdivision
area	I-Organism_subdivision
in	O
all	O
the	O
examined	O
animal	O
models	O
.	O

In	O
the	O
mammary	B-Cancer
carcinoma	I-Cancer
experiment	O
,	O
vascular	B-Multi-tissue_structure
permeability	O
measured	O
by	O
means	O
of	O
B22956	O
/	O
1	O
in	O
the	O
animals	O
treated	O
with	O
the	O
antiangiogenic	O
drug	O
(	O
0	O
.	O
0043317	O
+	O
/	O
-	O
0	O
.	O
0040418	O
ml	O
/	O
min	O
(	O
-	O
1	O
)	O
/	O
ml	O
(	O
-	O
1	O
)	O
)	O
was	O
significantly	O
less	O
than	O
in	O
untreated	O
animals	O
(	O
0	O
.	O
0090460	O
+	O
/	O
-	O
0	O
.	O
0043680	O
ml	O
/	O
min	O
(	O
-	O
1	O
)	O
/	O
ml	O
(	O
-	O
1	O
)	O
)	O
,	O
whereas	O
no	O
significant	O
difference	O
was	O
observed	O
with	O
Gd	O
-	O
DTPA	O
-	O
albumin	O
(	O
13	O
.	O
14	O
+	O
/	O
-	O
13	O
.	O
94	O
ml	O
/	O
min	O
(	O
-	O
1	O
)	O
/	O
ml	O
(	O
-	O
1	O
)	O
in	O
treated	O
animals	O
and	O
18	O
.	O
07	O
+	O
/	O
-	O
11	O
.	O
92	O
ml	O
/	O
min	O
(	O
-	O
1	O
)	O
/	O
ml	O
(	O
-	O
1	O
)	O
in	O
untreated	O
animals	O
)	O
.	O

In	O
the	O
colon	B-Cancer
carcinoma	I-Cancer
experiment	O
,	O
mean	O
permeability	O
and	O
perfusion	O
decreased	O
by	O
51	O
%	O
(	O
from	O
5	O
.	O
2	O
+	O
/	O
-	O
1	O
.	O
1	O
to	O
2	O
.	O
5	O
+	O
/	O
-	O
0	O
.	O
8	O
ml	O
/	O
100	O
ml	O
)	O
and	O
59	O
%	O
(	O
from	O
0	O
.	O
00165	O
+	O
/	O
-	O
5	O
.	O
1	O
to	O
0	O
.	O
0067	O
+	O
/	O
-	O
4	O
.	O
8	O
ml	O
/	O
min	O
(	O
-	O
1	O
)	O
/	O
ml	O
(	O
-	O
1	O
)	O
of	O
tissue	B-Tissue
)	O
,	O
respectively	O
,	O
in	O
all	O
animals	O
after	O
antiangiogenic	O
drug	O
administration	O
.	O

CONCLUSIONS	O
:	O
DCE	O
-	O
MRI	O
permits	O
a	O
noninvasive	O
evaluation	O
of	O
tumour	B-Cancer
microcirculation	O
and	O
in	O
particular	O
of	O
its	O
dynamic	O
characteristics	O
and	O
vascularity	O
before	O
and	O
after	O
antiangiogenic	O
treatment	O
.	O

